Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and Metformin

NCT03076112 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Ipragliflozin
DRUG: Sitagliptin

Sponsor

Seoul National University Bundang Hospital

Collaborators

[object Object]